Par Health recalls
2 notices naming Par Health as the recalling firm, since September 18, 2026. A notice covers specific products and lots, not every product of the firm.
Hazard and remedy text is quoted from the agency, unedited. The tag names the kind of risk with a word from that text. Every notice links to its official page.
Par Health Issues Voluntary Nationwide Recall of Two Lots of Brevital® Sodium 500 mg/vial CIV (Methohexital Sodium for Injection, USP) Due to the Presence of Particulate Matter
Hazard (FDA): Presence of particulate matter identified as cellulose
FDAMedicines
Par Health Issues Voluntary Nationwide Recall of Two Lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection Due to the Presence of Particulate Matter
Hazard (FDA): Presence of particulate matter identified as cellulose or stopper material
FDAMedicines